ALLIED INNOVATIVE SYSTEMS, LLC
Medtech · Private
Photochemical signal amplification method (PSAM) system for enhanced ELISA biomarker detection
- Grants
- $5.1M
- 10 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 4
- 3 granted · 1 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201420162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · A method for the determination of the percentage of CD4 T cells and CD4/CD8 ratio | $149,972 | |
| Federal grant | Department of Health and Human Services · Phase II · A new hemagglutination method for blood grouping | $495,210 | |
| Federal grant | Department of Health and Human Services · Phase II · A new hemagglutination method for blood grouping | $459,766 | |
| Federal grant | Department of Health and Human Services · Phase II · Ultra-sensitive method for HIV p24 antigen detection | $761,372 | |
| Federal grant | Department of Health and Human Services · Phase I · A multiplex assay for early detection of Cutaneous T-Cell Lymphoma | $219,104 | |
| Federal grant | Department of Health and Human Services · Phase II · Ultra-sensitive method for HIV p24 antigen detection | $705,376 | |
| Federal grant | Department of Health and Human Services · Phase I · Highly sensitive immunoassay for determination of biomarkers for neurodegenerative diseases | $422,885 | |
| Federal grant | Department of Health and Human Services · Phase I · Highly sensitive immunoassay for determination of biomarkers for neurodegenerative diseases | $34,270 | |
| Federal grant | Department of Health and Human Services · Phase II · Highly sensitive immunoassay for determination of biomarkers for neurodegenerative diseases | $977,713 | |
| Federal grant | Department of Health and Human Services · Phase II · Highly sensitive immunoassay for determination of biomarkers for neurodegenerative diseases | $845,968 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1387 | PERIKINETICS INC | — | — |
| 1388 | PREVENT BIOMETRICS, INC. | — | $4.2M |
| 1389 | Wobble Genomics Ltd | — | $254K |
| 1390 | ALLIED INNOVATIVE SYSTEMS, LLC | — | — |
| 1391 | Prellis Biologics, Inc | — | $47M |
| 1392 | HEALTH DISCOVERY LABS LLC | — | — |
| 1393 | DYMEDIX DIAGNOSTICS, INC. | — | $2.1M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Flow-through Cell Counting Assaygranted
- Methods For Improving Analyte Detection Using Photochemical Reactionsgranted
- Methods For Improving Analyte Detection Using Photochemical Reactionsgranted
- A Flow-through Cell Counting Assayapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.